Earnings Watch: Fidson’s 3Q Numbers, Revenue Leapfrogs Over 500%
Fidson Healthcare is having a bumper year as its revenue has appreciated over 500%.
The company, which produces Fast Moving Consumer Goods such as Fluffy Tissue, and Healthcare products such as Astymin (a malaria treatment drug), released its 3Q 2011 earnings on the floor of the exchange.
Revenue is up 527%, yes you are reading correctly, 527%: five hundred and twenty seven percent. The company reported that revenue leap frogged from just less than N 1 Billion a year ago to n 6.13 Billon at the end of September.
The company released its 3Q, 2011 financials on the floor of the NSE today.
Gross profit was reported as N 83.35 Million, up 67% from N 50 Million at the end of the same period last year.
Profit after tax was also N 83.3 Million as the company did not suffer any tax liability according to the released results.
PAT saw an improvement of 73.4% from the same period last year.
The company’s stock is trading at N 1.12, down 63% from the onset of the year.
-
FCMB Bank (UK) Limited Launches Personal and Business Banking Proposition to Deepen InclusivenessFCMB Bank (UK) Limited, an independently incorporated subsidiary of...
- August 1, 2018
-
The Worrisome Trend of Sensational Social Media “Journalism” and the Impact On Legitimate Business Concerns: Recent Travails of FCMB, GTBank and First BankOn June 25, 2018 I woke up to yet...
- June 26, 2018
-
Azman Air commences flight operation in SokotoAzman Air Thursday commenced flight operation to Sokoto state....
- February 21, 2015
-
NRC increases Lagos goods trains, eyes fuel haulageThe Nigerian Railway Corporation says it has increased its...
- June 23, 2016
